Ani Pharmaceuticals (ANIP) Price to FCF (2013 - 2026)

Ani Pharmaceuticals has disclosed Price to FCF across 14 years of filings, most recently posting 36.83 for Q2 2026.

• In Q2 2026, Price to FCF rose 81.54% year-over-year to 36.83; the TTM figure through Jun 2026 stood at 11.41 (down 1.69% YoY), while the FY2025 annual figure was 10.36, down 57.58% from the prior year.
• Price to FCF came in at 36.83 for Q2 2026 at Ani Pharmaceuticals, up from 34.93 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 486.97 in Q3 2022 to a low of 93.4 in Q4 2022.
• Average Price to FCF over 5 years is 67.55, with a median of 42.61 recorded in 2023.
• The largest YoY upside for Price to FCF was 795.6% in 2022 against a maximum downside of 200.93% in 2022.
• Over 5 years, Price to FCF stood at 93.4 in 2022, then surged by 128.82% to 26.92 in 2023, then soared by 221.87% to 86.65 in 2024, then retreated by 29.64% to 60.96 in 2025, then plunged by 39.59% to 36.83 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 36.83 in Q2 2026, 34.93 in Q1 2026, and 60.96 in Q4 2025.